Search results
Donegal patient hails positive results from Amyloidosis treatment trial - Donegal Daily
Donegal Daily· 13 hours agoA Donegal man who took part in an Amyloidosis treatment trial has welcomed positive developments...
Alnylam's heart disease drug meets main goal in late-stage study
Reuters· 5 days ago, opens new tab said on Monday that its drug vutrisiran met the main goal in a late-stage study testing it as a treatment for a type of heart disease. Treatment with the drug ...
Alnylam (ALNY) Soars as Heart Disease Drug Study Meets Goals
Zacks via Yahoo Finance UK· 4 days agoAlnylam (ALNY) soars as its phase III study, seeking to expand Anvuttra's label to include the...
Dog lovers paying up to £140 to discover their pet's breed
Daily Mail· 5 days ago'Virtually every recognised pedigree dog breed has a breed-specific predisposition to one or more ...
What’s Next For Alnylam Stock After A 60% Rise In A Week?
Forbes· 2 days agoThis can be attributed to positive data from a late-stage clinical trial for its cardiovascular...
FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
Zacks via Yahoo Finance UK· 3 days agoThe FDA grants priority review to Ionis' (IONS) filing seeking approval for olezarsen to treat...
Biotech Stock Roundup: ALNY Up on Study Success, ALIM on Merger News & Other Updates
Zacks via Yahoo Finance UK· 2 days agoKey measures of disease progression, such as the six-minute walk test, Kansas City Cardiomyopathy...
Is It Apt to Hold Quest Diagnostics (DGX) Stock for Now?
Zacks via Yahoo Finance UK· 3 days agoStrength in the core business bodes well for Quest Diagnostics (DGX). However, mounting debt levels...
Can my dog get cancer? Understanding the risks
The South African· 6 days agoCancer is indeed a daunting term for any pet owner, and our canine companions are also susceptible to this disease.
Billionaire Carlos Slim Ramps Up Oil Bets Amid Buying Spree
Bloomberg via Yahoo Finance UK· 1 day ago(Bloomberg) -- Carlos Slim, Latin America’s wealthiest man, is boosting oil and gas bets through...